✦ LIBER ✦

The clinical and economic benefits of administering piperacillin–tazobactam by continuous infusion

✍ Scribed by Srividya Kotapati; Joseph L. Kuti; Erika C. Geissler; Charles H Nightingale; David P Nicolau

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical cure of ventilator-associated p

✍ Leonardo Lorente; Alejandro Jiménez; María M. Martín; José Luis Iribarren; Juan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Steady-state pharmacokinetics and pharma

✍ Katherine M. Shea; S. Christian Cheatham; Matthew F. Wack; David W. Smith; Kevin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Steady-state pharmacokinetics and pharma

✍ S. Christian Cheatham; Megan R. Fleming; Daniel P. Healy; Christina E.K. Chung; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Clinical Efficacy and Pharmacoeconomics

✍ Edward M. Grant; Joseph L. Kuti; David P. Nicolau; Charles Nightingale; Richard 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Optimal Dosing of Piperacillin-Tazobacta

✍ Aryun Kim; Christina A. Sutherland; Joseph L. Kuti; Dr. David P. Nicolau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Clinical Outcomes With Extended or Conti

✍ Falagas, M. E.; Tansarli, G. S.; Ikawa, K.; Vardakas, K. Z. 📂 Article 📅 2012 🏛 University of Chicago Press 🌐 English ⚖ 473 KB